Crossmark

Efficacy and safety of dupilumab in patients with moderate-to-severe bullous pemphigoid: a systematic review and meta-analysis

Crossref DOI link: https://doi.org/10.1016/j.abd.2024.08.008

Published Print: 2025-05

Update policy: https://doi.org/10.1016/elsevier_cm_policy

Authors

da Silva, Júlia Opolski Nunes https://orcid.org/0000-0003-0903-7080
e Silva, Rodrigo Ribeiro https://orcid.org/0000-0001-9112-6511
Zattar Ribeiro, Paulo Victor https://orcid.org/0000-0002-6323-2234
Farah, Patrícia Silva https://orcid.org/0009-0007-4989-9909
Steglich, Raquel Bissacotti https://orcid.org/0000-0001-6550-3715
License Information

Text and Data Mining valid from 2025-05-01

Text and Data Mining valid from 2025-05-01

Version of Record valid from 2025-02-26
More Information

This article is maintained by: Elsevier

Article Title: Efficacy and safety of dupilumab in patients with moderate-to-severe bullous pemphigoid: a systematic review and meta-analysis

Journal Title: Anais Brasileiros de Dermatologia

CrossRef DOI link to publisher maintained version: https://doi.org/10.1016/j.abd.2024.08.008

Content Type: article

Copyright: © 2025 Sociedade Brasileira de Dermatologia. Published by Elsevier España, S.L.U.